THERAPEUTICSMD INC (TXMD)
US88338N2062 - Common Stock
On Monday, there are stocks with unusual volume. Let's take a look.
Let's explore the current happenings on the US markets on Monday. Below, you'll find the stocks exhibiting unusual volume in today's session.
In today's session, these stocks are experiencing unusual volume.
Volume analysis on 2025-01-03: stocks with an unusual volume in today's session.
TherapeuticsMD Announces Third Quarter 2024 Financial Results
TXMD Stock Earnings: TherapeuticsMD Reported Results for Q2 2024
TherapeuticsMD just reported results for the second quarter of 2024.
TXMD Stock Earnings: TherapeuticsMD Reported Results for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips TherapeuticsMD (NASDAQ:TXMD) just reported results for the second quarter of 20...
TherapeuticsMD Announces Second Quarter 2024 Financial Results
TXMD Stock Earnings: TherapeuticsMD Reported Results for Q4 2023
TherapeuticsMD just reported results for the fourth quarter of 2023.
TXMD Stock Earnings: TherapeuticsMD Reported Results for Q1 2024
TherapeuticsMD just reported results for the first quarter of 2024.
TXMD Stock Earnings: TherapeuticsMD Reported Results for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips TherapeuticsMD (NASDAQ:TXMD) just reported results for the first quarter of 202...
TherapeuticsMD Announces First Quarter 2024 Financial Results
TherapeuticsMD Announces Full Year 2023 Financial Results
TherapeuticsMD exploring strategic alternatives for company (NASDAQ:TXMD)
TherapeuticsMD (TXMD) said it is exploring strategic alternatives for the company, including a possible business combination or asset sale. Read more here.
TherapeuticsMD Announces Third Quarter 2023 Financial Results
TherapeuticsMD Announces Second Quarter 2023 Financial Results
TherapeuticsMD Announces First Quarter 2023 Financial Results
TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We're starting off the week with a breakdown of the biggest pre-market stock movers traders will want to watch for Monday!
TherapeuticsMD Completes Transaction to License Its Products to Mayne Pharma
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
TherapeuticsMD Announces Third Quarter 2022 Financial Results
TherapeuticsMD Announces Additional $7 Million Private Placement
TherapeuticsMD Announces $7 Million Private Placement
